Hantavirus infection overview: Difference between revisions
Usama Talib (talk | contribs) No edit summary |
Usama Talib (talk | contribs) |
||
| Line 13: | Line 13: | ||
Hantavirus infection can be classified on the basis of the clinical manifestations and the type of hantavirus responsible for the manifestation. The clinical manifestations may include hantavirus cardiopulmonary syndrome (HCPS), hemorrhagic fever with renal syndrome (HFRS) and nephropathia epidemica (NE).<ref name="pmid28120221">{{cite journal| author=Jiang H, Zheng X, Wang L, Du H, Wang P, Bai X| title=Hantavirus infection: a global zoonotic challenge. | journal=Virol Sin | year= 2017 | volume= 32 | issue= 1 | pages= 32-43 | pmid=28120221 | doi=10.1007/s12250-016-3899-x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28120221 }}</ref> | Hantavirus infection can be classified on the basis of the clinical manifestations and the type of hantavirus responsible for the manifestation. The clinical manifestations may include hantavirus cardiopulmonary syndrome (HCPS), hemorrhagic fever with renal syndrome (HFRS) and nephropathia epidemica (NE).<ref name="pmid28120221">{{cite journal| author=Jiang H, Zheng X, Wang L, Du H, Wang P, Bai X| title=Hantavirus infection: a global zoonotic challenge. | journal=Virol Sin | year= 2017 | volume= 32 | issue= 1 | pages= 32-43 | pmid=28120221 | doi=10.1007/s12250-016-3899-x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28120221 }}</ref> | ||
==Pathophysiology== | ==Pathophysiology== | ||
[[Hantavirus]] | [[Hantavirus]] is usually transmitted via the inhalation of aerosolized viral antigens or rodent bites. The incubation period of hantavirus infection is of 9 to 33 days. Following inhalation, the virus replicates in pulmonary macrophages and dendritic cells. The primary target cells of hantavirus infection are endothelial cells of capillaries. Infection is followed by impairment of the barrier function of endothelial cells, fluid extravasation, and subsequent organ failure. | ||
==Causes== | ==Causes== | ||
==Differentiating Hantavirus from other Diseases== | ==Differentiating Hantavirus from other Diseases== | ||
Revision as of 20:10, 7 July 2017
|
Hantavirus infection Microchapters |
|
Patient Information |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hantavirus infection overview On the Web |
|
American Roentgen Ray Society Images of Hantavirus infection overview |
|
Directions to Hospitals Treating Hantavirus pulmonary syndrome |
|
Risk calculators and risk factors for Hantavirus infection overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Hantavirus pulmonary syndrome (HPS) is a deadly disease from rodents.
Historical Perspective
In May 1993, an outbreak of an unexplained pulmonary illness occurred in the southwestern United States, in an area shared by Arizona, New Mexico, Colorado and Utah known as "The Four Corners." A young, physically fit Navajo man suffering from shortness of breath was rushed to a hospital in New Mexico and died very rapidly.
Classification
Hantavirus infection can be classified on the basis of the clinical manifestations and the type of hantavirus responsible for the manifestation. The clinical manifestations may include hantavirus cardiopulmonary syndrome (HCPS), hemorrhagic fever with renal syndrome (HFRS) and nephropathia epidemica (NE).[1]
Pathophysiology
Hantavirus is usually transmitted via the inhalation of aerosolized viral antigens or rodent bites. The incubation period of hantavirus infection is of 9 to 33 days. Following inhalation, the virus replicates in pulmonary macrophages and dendritic cells. The primary target cells of hantavirus infection are endothelial cells of capillaries. Infection is followed by impairment of the barrier function of endothelial cells, fluid extravasation, and subsequent organ failure.
Causes
Differentiating Hantavirus from other Diseases
Epidemiology and Demographics
Risk Factors
Little is known about activities that lead to a greater risk of infection. However, an early case-control study suggests that increased numbers of rodents in the household is the strongest risk factor for infection.
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
=Physical Examination
Laboratory Findings
A positive serological test result, evidence of viral antigen in tissue by immunohistochemistry, or the presence of amplifiable viral RNA sequences in blood or tissue, with compatible history of HPS, is considered diagnostic for HPS.
X ray
CT scan
MRI
=Ultrasound
Other Imaging findings
Other Diagnostic Studies
Treatment
Medical Therapy
There is no specific treatment, cure, or vaccine for hantavirus infection. However, we do know that if infected individuals are recognized early and receive medical care in an intensive care unit, they may do better.
Surgery
Primary Prevention
Eliminate or minimize contact with rodents in your home, workplace, or campsite. Seal up holes and gaps in your home or garage. Place traps in and around your home to decrease rodent infestation. Clean up any easy-to-get food. Recent research results show that many people who became ill with HPS developed the disease after having been in frequent contact with rodents and/or their droppings around a home or a workplace. On the other hand, many people who became ill reported that they had not seen rodents or rodent droppings at all. Therefore, if you live in an area where the carrier rodents are known to live, try to keep your home, vacation place, workplace, or campsite clean.
Secondary Prevention
References
- ↑ Jiang H, Zheng X, Wang L, Du H, Wang P, Bai X (2017). "Hantavirus infection: a global zoonotic challenge". Virol Sin. 32 (1): 32–43. doi:10.1007/s12250-016-3899-x. PMID 28120221.